| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027888 |
| Receipt No. | R000031955 |
| Scientific Title | A retrospective observational study for elderly patients with uterine cervical cancer using image guided brachytherapy |
| Date of disclosure of the study information | 2017/07/01 |
| Last modified on | 2021/06/08 (Ver. 8) |
| Basic information | ||
| Public title | A retrospective observational study for elderly patients with uterine cervical cancer using image guided brachytherapy | |
| Acronym | A retrospective observational study for elderly patients with uterine cervical cancer using image guided brachytherapy | |
| Scientific Title | A retrospective observational study for elderly patients with uterine cervical cancer using image guided brachytherapy | |
| Scientific Title:Acronym | A retrospective observational study for elderly patients with uterine cervical cancer using image guided brachytherapy | |
| Region |
|
|
| Condition | ||
| Condition | uterine cervical cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the efficacy and toxicity of image guided brachytherapy for elderly patients with uterine cervical cancer, retrospectively. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Three-year local control, cause-specific survival, and overall survival rates.
Incidence of Grade 1 or worse late toxicities. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Among patients who underwent image guided brachytherapy in our hospital between January 2001 and September 2014, patients who meet the following eligible criteria.
1) histologically proven, untreated uterine cervical squamous cell carcinoma 2) an International Federation of Gynecology and Obstetrics (FIGO) stage of IB1-IVA 3) treated with curative intent 4) IGBT performed at least once during the whole session of intracavitary brachytherapy |
|||
| Key exclusion criteria | treated for palliative | |||
| Target sample size | 105 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Institutes for Quantum and Radiological Sciences and Technology | ||||||
| Division name | Hospital of the National Institute of Radiological Sciences | ||||||
| Zip code | 263-8555 | ||||||
| Address | Anagawa 4-9-1, Inage-ku 263-8555 Chiba, Japan | ||||||
| TEL | 043-206-3306 | ||||||
| okonogi.noriyuki@qst.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Institutes for Quantum and Radiological Sciences and Technology | ||||||
| Division name | Hospital of the National Institute of Radiological Sciences | ||||||
| Zip code | 263-8555 | ||||||
| Address | Anagawa 4-9-1, Inage-ku 263-8555 Chiba, Japan | ||||||
| TEL | 043-206-3306 | ||||||
| Homepage URL | |||||||
| m15702037@gunma-u.ac.jp | |||||||
| Sponsor | |
| Institute | Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | National Institutes for Quantum and Radiological Sciences and Technology |
| Address | Anagawa 4-9-1, Inage-ku 263-8555 Chiba, Japan |
| Tel | 043-206-3306 |
| m15702037@gunma-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.brachyjournal.com/article/S1538-4721(19)30022-4/fulltext |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.brachyjournal.com/article/S1538-4721(19)30022-4/fulltext | ||||||
| Number of participants that the trial has enrolled | 105 | ||||||
| Results | The 5-year local control and cause-specific survival rates were 89% and 78%, respectively. | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | A total of 105 consecutive patients with cervical squamous cell carcinoma aged 70 years or elderly who received radiotherapy alone between January 2001 and September 2014. All patients were treated with external beam radiotherapy and high-dose-rate intracavitary brachytherapy. | ||||||
| Participant flow | a retrospective chart review | ||||||
| Adverse events | The 5-year cumulative rates of late toxicities of the rectum and bladder of Grade 3 or worse were 2.0% and 4.2%, respectively. | ||||||
| Outcome measures | The 5-year local control and cause-specific survival rates were 89% and 78%, respectively. | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Among patients who underwent image guided brachytherapy in our hospital between January 2001 and September 2014, patients who meet the following eligible criteria.
1) histologically proven, untreated uterine cervical squamous cell carcinoma 2) an International Federation of Gynecology and Obstetrics (FIGO) stage of IB1-IVA 3) treated with curative intent 4) IGBT performed at least once during the whole session of intracavitary brachytherapy |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031955 |